Cameroon vs Sierra Leone: Access to anti-retroviral drugs, female
Cameroon
95.0%
in 2024
Sierra Leone
95.0%
in 2024
Cameroon rank
19th
Sierra Leone rank
19th
Access to anti-retroviral drugs, female over time
- Cameroon
- Sierra Leone
How they compare
Cameroon currently reports 95.0% against 95.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Sierra Leone ahead.
Cameroon ranks 19th and Sierra Leone ranks 19th of 141 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 1.5% | 2.7% | Cameroon |
| 2010s | 38.0% | 28.4% | 9.6% | Cameroon |
| 2020s | 86.6% | 80.4% | 6.2% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cameroon or Sierra Leone?
- Cameroon, at 95.0% against 95.0% in Sierra Leone as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cameroon and Sierra Leone?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Sierra Leone?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Sierra Leone rank globally for access to anti-retroviral drugs, female?
- Cameroon ranks 19th and Sierra Leone ranks 19th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.